Research · Earnings calendar · IDXX
IDEXX Laboratories, Inc.: results reported 2 November 2026
Written 17 November 2026 from public records. Prices are closing prices to 16 November 2026. Tables are built by the same arithmetic for every company on the calendar; no analyst wrote this page.
What was reported
IDEXX Laboratories, Inc. reported on Monday 2 November 2026. Earnings per share were $3.98. The analysts' average estimate listed by Nasdaq was $3.71, so the result was $0.27 above it. The time of the release was not given, so we do not name one reaction day. The shares closed at $551.21 the day before, $671.64 on the day and $700.65 on 16 Nov.
This page was first written on 17 November 2026, after these results. No preview was written beforehand, so there is nothing of ours to compare the result with. The estimate is a per-share figure collected by Nasdaq's data supplier and may be on a different basis from the company's own headline number.
The chart: above both averages
IDEXX Laboratories, Inc. closed at $700.65 on 16 November 2026. Over the past year the shares are up 2%. That is 9% below the highest close of the year, $766.68 on 25 Nov.
- Highest close of the year: $766.68 on 25 Nov.
- Lowest close of the year: $504.70 on 11 Sep.
- Last crossed above the 50-day average on 15 Oct.
- Last crossed above the 200-day average on 2 Nov.
- Results on 2 Nov.
| Measure | Reading | In plain words |
|---|---|---|
| 50-day average | $565.71 | The close is 24% above it. It has been on that side since 15 Oct. |
| 200-day average | $572.50 | The close is 22% above it. It has been on that side since 2 Nov. |
| Distance from the year's high | 9% below | The high was $766.68 on 25 Nov. |
| 14-day RSI | 70 | Over 70 is the usual line for “overbought”. It describes how fast the price rose, not where it goes next. |
| Volume | 0.5 million on 16 Nov | 1.0 times a normal day (0.5 million, the median of the 60 sessions before). |
Who holds IDEXX Laboratories, Inc., and who changed
Managers with $100 million or more in U.S. listed securities report their holdings to the SEC each quarter on Form 13F, within 45 days of the quarter end. At 30 June, 1,306 managers reported 74 million shares, about 95% of the company (91% at 31 March). The reports for 30 September were due on 16 November.
| Holder | What kind of account | 30 June | 30 September | Change | Share of company |
|---|---|---|---|---|---|
| BlackRock, Inc. | Mostly index funds | 8.2 | 8.1 | -0.9% | 10.3% |
| Vanguard Capital Management | Mostly index funds | 5.2 | 5.2 | +0.1% | 6.5% |
| Vanguard Portfolio Management | Mostly index funds | 3.9 | 4.0 | +1.5% | 5.0% |
| State Street | Mostly index funds | 3.7 | 3.8 | +0.3% | 4.8% |
| Invesco Ltd. | Asset manager | 3.6 | 3.4 | -6.6% | 4.3% |
| Geode Capital | Mostly index funds | 2.6 | 2.6 | +2.3% | 3.3% |
| Bamco Inc | Asset manager | 2.0 | 1.8 | -9.8% | 2.3% |
| Morgan Stanley | Bank: dealer book, asset and wealth arms | 1.4 | 1.4 | +1.3% | 1.7% |
| Bank of New York Mellon Corp | Asset manager | 1.2 | 0.9 | -21.4% | 1.2% |
| Arrowstreet Capital, Limited Partnership | Asset manager | 1.1 | 1.4 | +27.4% | 1.7% |
| The 10 read, together | 32.7 | 32.4 | -1.0% | 41.2% |
What it shows. Cut by 5% or more: Bank of New York Mellon Corp (-21%), Bamco Inc (-10%), Invesco Ltd. (-7%). Added 5% or more: Arrowstreet Capital, Limited Partnership (+27%). These are positions at 30 September. Buying or selling since then is not in any filing yet.
Sources: SEC Form 13F data sets for 30 June (all filers); each holder's own Form 13F for 30 September, read through 13f.info, which republishes the SEC filings. Long share positions only; options and bonds are left out. A bank's filing mixes its trading book with money it manages for clients. Index funds hold a stock at its index weight, so their small changes mostly follow money moving in and out of the funds.
Who has been buying or selling lately
No public record names recent buyers or sellers. Exchanges publish prices and volume, not identities. Each kind of account is disclosed on its own delay.
| Kind of account | When it is disclosed | What the record shows now |
|---|---|---|
| Officers and directors | Form 4, within two business days of a trade | In the last 30 days the SEC index for the company lists 6 Form 4 filings and 4 Form 144 notices of a planned sale. A Form 4 can report a sale, a purchase, a grant or shares withheld for tax; we count the filings here and have not read their contents. |
| Funds, pensions, banks | Form 13F, 45 days after each quarter end | Positions at 30 September, above. Trading since then first appears in the 31 December reports, due in mid-February 2027. |
| Holders of 5% or more | Schedule 13G or 13D, after a material change | 1 schedule filed since 1 October. |
What the business numbers show
In the latest reported quarter, to 30 September 2026, revenue was $1.2 billion, up 10% on a year earlier. The quarter before, growth was +10%, so growth was steady. Operating margin was 33.1%, against 32.1% in the same quarter a year earlier.
| Quarter ended | Revenue | On a year earlier | Gross margin | Operating margin | Net income | Earnings per share, diluted |
|---|---|---|---|---|---|---|
| 30 June 2025 | $1.1 billion | +11% | 62.6% | 33.6% | $294 million | $3.63 |
| 30 September 2025 | $1.1 billion | +13% | 61.8% | 32.1% | $275 million | $3.40 |
| 31 March 2026 | $1.1 billion | +14% | 63.4% | 31.8% | $278 million | $3.47 |
| 30 June 2026 | $1.2 billion | +10% | 64.0% | 35.0% | $338 million | $4.27 |
| 30 September 2026 | $1.2 billion | +10% | 62.9% | 33.1% | $317 million | $4.01 |
Source: the company's reports to the SEC (XBRL company facts, data.sec.gov), CIK 874716. Figures are as filed and are restated when the company restates them. Banks, insurers and some other companies do not report gross or operating profit.